Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04624087 · ClinicalTrials.gov registry record · NA
Go/No-Go Intervention for Weight Loss
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT04624087: Completed NA study, sponsored by University of Minnesota.
NCT04624087 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04624087, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of a food-specific Go/No-Go (GNG) computerized training task on weight loss, food evaluation, and disinhibition in a population of overweight and obese individuals.
Primary Outcome
Body weight will be measured by participant using personal or university scale. Participants will take a picture of their weight send it to the research team (Due to COVID-19 precautions, in person weighing is not possible).
Interventions
- BEHAVIORAL food-specific go/no-go computerized training
- BEHAVIORAL nonfood-specific go/no-go computerized training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2020-10-19 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
What the finished NCT04624087 record still lists
NCT04624087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which food-specific go/no-go computerized training is the first listed.
NCT04624087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04624087 about?
NCT04624087 is a clinical study titled "Go/No-Go Intervention for Weight Loss". The purpose of this study is to assess the effect of a food-specific Go/No-Go (GNG) computerized training task on weight loss, food evaluation, and disinhibition in a population of overweight and obese individuals.
What is the current status of trial NCT04624087?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2020-10-19. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT04624087?
The interventions under investigation include: food-specific go/no-go computerized training (BEHAVIORAL), nonfood-specific go/no-go computerized training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04624087?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04624087's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI